We are live on ! Find out more
ORPH

Orphazyme A/S

Delisted

ORPH was delisted on the 30th of March, 2022.

16 hedge funds and large institutions have $35.9M invested in Orphazyme A/S in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
IM
1
Islet Management
New York
$14M +$13.6M +1,353,768 New
Bank of America
2
Bank of America
North Carolina
$5.46M +$5.3M +528,991 New
GCP
3
GSA Capital Partners
United Kingdom
$5.06M +$4.91M +490,000 New
Citadel Advisors
4
Citadel Advisors
Florida
$2.07M +$2M +200,000 New
CH
5
CVI Holdings
Delaware
$1.81M +$1.75M +175,000 New
MIM
6
Monashee Investment Management
Massachusetts
$1.81M +$1.75M +175,000 New
SSA
7
Schonfeld Strategic Advisors
New York
$1.54M +$1.5M +149,500 New
MS
8
Maven Securities
Jersey
$1.3M +$1.29M +128,844 New
HP
9
Hound Partners
New York
$1.03M +$1M +100,000 New
MWNA
10
Marshall Wace North America
New York
$840K +$815K +81,332 New
SIGI
11
Susquehanna International Group (Ireland)
Ireland
$510K +$495K +49,400 New
CCM
12
CAAS Capital Management
New York
$258K +$251K +25,000 New
AI
13
Atom Investors
Texas
$103K +$100K +10,000 New
FIA
14
FNY Investment Advisers
New York
$96K +$93.2K +9,300 New
PA
15
Parallel Advisors
California
$4K +$4.01K +400 New
Millennium Management
16
Millennium Management
New York
$2.04K +$1.98M +197,556 New